Clinical Trial Update: Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pegylated interferon alpha-2b with hydroxyurea in polycythemia vera has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)
• Pegylated Interferon Alpha-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: AOP Orphan Pharmaceuticals AG | Conditions: Polycythemia Vera | Phase 3 | Status: COMPLETED